Clinical Trial Update: Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030) [Phase 3]

View source ↗

Summary

Phase 3 trial examining the addition of ezetimibe to atorvastatin in individuals with coronary heart disease or multiple cardiovascular risk factors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED